Show simple item record

dc.contributor.authorShapey, Iestyn M; orcid: 0000-0003-3300-1053; email: iestyn.shapey@manchester.ac.uk
dc.contributor.authorSummers, Angela
dc.contributor.authorKhambalia, Hussein
dc.contributor.authorYiannoullou, Petros
dc.contributor.authorFullwood, Catherine
dc.contributor.authorHanley, Neil A
dc.contributor.authorAugustine, Titus
dc.contributor.authorRutter, Martin K
dc.contributor.authorvan Dellen, David
dc.date.accessioned2021-07-10T01:45:35Z
dc.date.available2021-07-10T01:45:35Z
dc.date.issued2021-06-25
dc.date.submitted2021-04-29
dc.identifierpubmed: 34173017
dc.identifierdoi: 10.1007/s00125-021-05502-7
dc.identifierpii: 10.1007/s00125-021-05502-7
dc.identifier.citationDiabetologia
dc.identifier.urihttp://hdl.handle.net/10034/625209
dc.descriptionFrom PubMed via Jisc Publications Router
dc.descriptionHistory: received 2021-04-29, accepted 2021-05-04
dc.descriptionPublication status: aheadofprint
dc.languageeng
dc.sourceeissn: 1432-0428
dc.titleDonor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Reply to Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ et al [letter].
dc.typeother
dc.date.updated2021-07-10T01:45:34Z
dc.date.accepted2021-05-04


This item appears in the following Collection(s)

Show simple item record